Are new diabetes drugs approved too easily? episode artwork

EPISODE · Oct 19, 2015 · 25 MIN

Are new diabetes drugs approved too easily?

from Medicine and Science from The BMJ · host The BMJ

Given the number of effective treatments for type II diabetes, which have good evidence about safety and efficacy, should any new drugs for the condition be subject to a higher regulatory bar? In this podcast, Huseyin Naci from the London School of Economics, John Yudkin from Univerity College London, and Ben Goldacre from the University of Oxford, explain why they believe the current process is inadequate, and suggest some ways in which it could be improved. Read the full analysis article: http://www.bmj.com/content/351/bmj.h5260

NOW PLAYING

Are new diabetes drugs approved too easily?

0:00 25:24

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of Medicine and Science from The BMJ?

This episode is 25 minutes long.

When was this Medicine and Science from The BMJ episode published?

This episode was published on October 19, 2015.

What is this episode about?

Given the number of effective treatments for type II diabetes, which have good evidence about safety and efficacy, should any new drugs for the condition be subject to a higher regulatory bar? In this podcast, Huseyin Naci from the London School of...

Can I download this Medicine and Science from The BMJ episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!